Overview

A Study of the Pharmacokinetics of Golimumab in Chinese Male Subjects

Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics of golimumab in Chinese male participants.
Phase:
Phase 1
Details
Lead Sponsor:
Centocor, Inc.
Treatments:
Antibodies, Monoclonal
Golimumab